Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients with gastroenteropancreatic neuroendocrine tumors, a phase 3 trial found.

Neuroendocrine cancers are a ... organs of the body such as the bowel, lungs and liver. It’s a worrying time for many people and we want to be there for you whenever - and wherever - you need us.

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

T-cells from the liver and lymph nodes show promising potential for future treatments of liver cancer, according to a new study. Researchers at Karolinska Institutet have investigated how immune ...

For information and support, you can call the Cancer Research UK information nurses on freephone 0808 800 4040. The lines are open from 9am to 5pm, Monday to Friday. Most people have several tests to ...

The combination of chemotherapy and radioembolization appeared safe and effective in patients with well-differentiated, liver-dominant, grade 3 NETs.

The team demonstrated this both in mouse liver cancer cells and in several human cancer cell lines. The findings are published in the journal Nature Metabolism. However, when the researchers ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA. From “Boy Meets World” actress Danielle ...

Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer. First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB ...

More reason to move: Physically active people at risk for liver cancer may be up to 60 percent less likely to develop the disease. Regular activity also protects your heart — an important ...